Adult Dosing
Asthma
Foradil Aerolizer
- 12 mcg CAP q12 hrs, concomitant use as a combination with other asthma controller medications
Foradil Certihaler
- 10 mcg INH q12 hrs (Note: approximately 8.5 mcg of formoterol fumarate is delivered by each actuation of Foradil Certihaler, corresponding to a metered dose of 10 mcg of formoterol fumarate)
Exercise-induced bronchospasm
Foradil Aerolizer
- 12 mcg/cap CAP 15 mins prior to exercise. Max: 24 mcg/day; concomitant use as a combination with other asthma controller medications in patients with persistent asthma
COPD
Foradil Aerolizer
Perforomist
- 20 mcg INH q12 hrs; Max: 40 mcg/day
Prevention of bronchospasm
Foradil Certihaler
- 12 mcg/cap INH 15 mins prior to exercise. Max: 24 mcg/day; concomitant use as a combination with other asthma controller medications in patients with persistent asthma
Pediatric Dosing
Asthma
Foradil Aerolizer
- >5 yrs: 12 mcg INH q12 hrs; Max: 24 mcg/day
Exercise-induced bronchospasm
- >5 yrs: 12 mcg INH should be inhaled 15 mins prior to exercise
Asthma
Foradil Certihaler
- >5 yrs: 10 mcg INH q12 hrs
COPD
Perforomist
- Safety and effectiveness in pediatric patients have not been established
[Outline]
See Supplemental Patient Information
- Increased risk of asthma related death; insufficient data to determine whether concomitant use of inhaled corticosteriods or other long term asthma control medications mitigate increased risk of asthma-related death [US Black Box Warning]
- Do not exceed recommended dosage
- Use only in combination with long-term asthma control medication e.g. corticosteroids. Do not use if asthma is adequately controlled on low or medium dose inhaled corticosteroids
- Long acting beta2 agonists increase the risk of asthma-related hospitalization in adolescent and pediatric patients; use fixed dose combination of an inhaled corticosteroid and long acting beta2 agonists
- Risk of higher incidence of serious asthma exacerbations vs. placebo; do not initiate in patients with significantly worsening or acutely deteriorating asthma
- Do not use in conjunction with an inhaled, long-acting beta2-agonist
- It is not a substitute for inhaled or oral corticosteroids; do not stop or reduce dosage of corticosteroids at the of starting therapy with formoterol
- Instruct patients who have been taking inhaled, short-acting beta2-agonists on a regular basis to discontinue and use those drugs only for symptomatic relief of acute symptoms
- Can produce life-threatening paradoxical bronchospasm
- Hypersensitivity reactions like anaphylactic reactions, angioedema, bronchospasm, rash, and urticaria may occur
- Clinically significant changes in SBP and/or DBP pulse rate and electrocardiograms have occurred
Cautions: Use cautiously in
- Hypersensitivity to milk proteins
- Cardiovascular disorders
- Coronary insufficiency
- Cardiac arrhythmias
- Hypertension
- Diabetes
- Convulsive disorders
- Thyrotoxicosis
- Thyroid disorder
- Hypokalemia
Supplemental Patient Information
- Patient should be instructed to read the accompanying medication guide with each new prescription supplied with the product
Pregnancy Category:C
Breastfeeding: Safety unknown; use of inhaled bronchodilators may be considered acceptable with breastfeeding due to low bioavailability and maternal serum levels. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 29 September 2010). Manufacturer advises caution.
Pricing data from www.DrugStore.com in U.S.A.
- Foradil Aerolizer 12 MCG CAPS [Box] (SCHERING)
60 mcg = $175.99
180 mcg = $499.97
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
Drug Name: Foradil 0.012 MG/ACTUAT Inhalant Powder
Ingredient(s): Formoterol
Imprint: CG;FXF
Color(s): White
Shape: Capsule
Size (mm): 16.00
Score: 1
Inactive Ingredient(s): lactose
Drug Label Author:
Merck & Co., Inc
DEA Schedule:
Non-Scheduled
